Telomere length in hepatocellular carcinoma and paired adjacent non-tumor tissues by quantitative PCR

Cancer Investigation

Volumn 25, Issue 8, 2007, Pages 668-677

  Zhang, Yujing ^a   Shen, Jing ^a   Ming Whei, ^b   Lee, Yu Po Huang ^c   Santella, Regina M ^a  

^a Department of Medicine   (United States)

^b Affiliated Faculty Global Institute of Public Health   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Biomarkers; Liver cancer; Quantitative real time PCR; Telomeric repeat

Indexed keywords

AFLATOXIN B1; CARCINOGEN; DNA; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P16; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENE MUTATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; TELOMERE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENES, P53; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; TELOMERE;

EID: 36849059171     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701561024     Document Type: Article

References (55)

1. Blackburn, E.H.; Greider, C.W. Telomeres. Cold Spring Harbor Laboratory Press, New York, 1995.
2. Harley, C.B.; Futcher, A.B.; Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345, 458-460.
3. Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; Harley, C.B.; West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
4. Blackburn, E.H. Switching and signaling at the telomere. Cell 2001, 106, 661-673.
5. Collins, K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 2000, 12, 378-383.
6. Slagboom, P.E.; Droog, S.; Boomsma, D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am.J.Hum.Genet. 1994, 55, 876-882.
7. Coviello-McLaughlin, G.M.; Prowse, K.R. Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res. 1997, 25, 3051-3058.
8. Ulaner, G.A.; Hu, J.F.; Vu, T.H.; Giudice, L.C.; Hoffman, A.R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998, 58, 4168-4172.
9. Oh, B.K.; Kim, Y.J.; Park, C.; Park, Y.N. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol. 2005, 166, 73-80.
10. Hastie, N.D.; Dempster, M.; Dunlop, M.G.; Thompson, A.M.; Green, D.K.; Allshire, R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346, 866-868.
11. Nurnberg, P.; Thiel, G.; Weber, F.; Epplen, J.T. Changes of telomere lengths in human intracranial tumours. Hum. Genet. 1993, 91, 190-192.
12. El Serag, H.B. Hepatocellular carcinoma: an epidemiologic view. J. Clin. Gastroenterol. 2002, 35, S72-S78.
13. Beasley, R.P. Hepatitis B Virus: The major etiology of hepatocellular carcinoma. Cancer 1988, 15, 1942-1956.
14. Chen, C.J.; Yu, M.W.; Liaw, Y.F. Epidemiologic characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1997, 12, S294-308.
15. Santella, R.M.; Chen, C.J.; Zhang, Y.J.; Yu, M.W.; Wang, L.Y. Biological markers of aflatoxin B1 in hepatocellular cancer in Taiwan. In Mendelsohn, M.L., Mohr, L.C., and Peeters, J.P. (eds.) Biomarkers medical and workplace applications. Joseph Henry Press, Washington, DC, 1998, pp 355-364.
16. Buetow, K.H.; Murray, J.C.; Isreal, J.L.; London, W.T.; Smith, M.; Kew, M.; Blanquet, V.; Brechot, C.; Redker, A.; Govindarajah, S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 1989, 86, 8852-8856.
17. Murakami, Y.; Hayashi, K.; Hirohashi, S.; Sekiya, T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocelluar carcinomas. Cancer Res. 1991, 51, 5520-5525.
18. Zhang, Y.J.; Jiang, W.; Chen, C.J.; Lee, C.S.; Kahn, S.M.; Santella, R.M.; Weinstein, I.B. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochemical & Biophysical Research Communications 1993, 196, 1010-1016.
19. Hui, A.M.; Li, X.; Makuuchi, M.; Takayama, T.; Kubota, K. Overexpression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. International Journal of Cancer 1999, 84, 604-608.
20. Wong, I.H.; Lo, Y.M.; Yeo, W.; Lau, W.Y.; Johnson, P.J. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin. Cancer Res. 2000, 6, 3516-3521.
21. Zhang, Y.J.; Ahsan, H.; Chen, Y.; Lunn, R.M.; Wang, L.Y.; Chen, S.Y.; Lee, P.H.; Chen, C.J.; Santella, R.M. High frequency of promoter hypermethylation of the RASSF1A and p16 genes and its relationship to aflatoxin B1-DNA adducts level in human hepatocellular carcinoma. Mol. Carcinogenesis 2002, 35, 85-92.
22. 6-methylguanine- DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutations in hepatocellular carcinoma. Int. J. Cancer 2003, 103, 440-444.
23. Zhong, S.; Tang, M.W.; Yeo, W.; Liu, C.; Lo, Y.M.; Johnson, P.J. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin. Cancer Res. 2002, 8, 1087-1092.
24. Kojima, H.; Yokosuka, O.; Imazeki, F.; Saisho, H.; Omata, M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997, 12, 493-500.
25. Isokawa, O.; Suda, T.; Aoyagi, Y.; Kawai, H.; Yokota, T.; Takahashi, T.; Tsukada, K.; Shimizu, T.; Mori, S.; Abe, Y.; Suzuki, Y.; Nomoto, M.; Mita, Y.; Yanagi, M.; Igarashi, H.; Asakura, H. Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis. Hepatology 1999, 30, 408-412.
26. Miura, N.; Horikawa, I.; Nishimoto, A.; Ohmura, H.; Ito, H.; Hirohashi, S.; Shay, J.W.; Oshimura, M. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet. 1997, 93, 56-62.
27. Huang, G.T.; Lee, H.S.; Chen, C.H.; Chiou, L.L.; Lin, Y.W.; Lee, C.Z.; Chen, D.S.; Sheu, J.C. Telomerase activity and telomere length in human hepatocellular carcinoma. Eur. J. Cancer 1998, 34, 1946-1949.
28. Cawthon, R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30, e47.
29. Zhang, Y.J.; Rossner P.; Chen, Y.; Agrawal, M.; Wang, Q.; Wang, L.; Ahsan, H.; Yu, M.W.; Lee, P.H.; Santella, R.M. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. International Journal of Cancer, 2006, 119, 985-991.
30. Vaziri, H.; Benchimol, S. From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp. Gerontol. 1996, 31, 295-301.
31. Chin, L.; Artandi, S.E.; Shen, Q.; Tam, A.; Lee, S.L.; Gottlieb, G.J.; Greider, C.W.; DePinho, R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97, 527-538.
32. Lengauer, C.; Kinzler, K.W.; Vogelstein, B. Genetic instabilities in human cancers. Nature 1998, 396, 643-649.
33. Blackburn, E.H. Structure and function of telomeres. Nature 1991, 350, 569-573.
34. Zakian, V.A. Telomeres: beginning to understand the end. Science 1995, 270, 1601-1607.
35. Levy, M.Z.; Allsopp, R.C.; Futcher, A.B.; Greider, C.W.; Harley, C.B. Telomere end-replication problem and cell aging. J. Mol. Biol. 1992, 225, 951-960.
36. Plentz, R.R.; Caselitz, M.; Bleck, J.S.; Gebel, M.; Flemming, P.; Kubicka, S.; Manns, M.P.; Rudolph, K.L. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology 2004, 40, 80-86.
37. Satyanarayana, A.; Manns, M.P.; Rudolph, K.L. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 2004, 40, 276-283.
38. Artandi, S.E.; Chang, S.; Lee, S.L.; Alson, S.; Gottlieb, G.J.; Chin, L.; DePinho, R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406, 641-645.
39. Rudolph, K.L.; Chang, S.; Lee, H.W.; Blasco, M.; Gottlieb, G.J.; Greider, C.; DePinho, R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96, 701-712.
40. Lechel, A.; Manns, M.P.; Rudolph, K.L. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 2004, 41, 491-497.
41. Lin, K.W.; Yan, J. The telomere length dynamic and methods of its assessment. J. Cell Mol. Med. 2005, 9, 977-989.
42. Baird, D.M. New developments in telomere length analysis. Exp. Gerontol. 2005, 40, 363-368.
43. Bekaert, S.; De Meyer, T.; Van Oostveldt, P. Telomere attrition as ageing biomarker. Anticancer Res. 2005, 25, 3011-3021.
44. Blasco, M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6, 611-622.
45. Valdes, A.M.; Andrew, T.; Gardner, J.P.; Kimura, M.; Oelsner, E.; Cherkas, L.F.; Aviv, A.; Spector, T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366, 662-664.
46. von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27, 339-344.
47. Broberg, K.; Bjork, J.; Paulsson, K.; Hoglund, M.; Albin, M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26, 1263-1271.
48. Hsu, I.C.; Metcalf, R.A.; Sun, T.; Welsh, J.A.; Wang, N.J.; Harris, C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991, 350, 427-428.
49. Lunn, R.M.; Zhang, Y.J.; Wang, L.Y.; Chen, C.J.; Lee, P.H.; Lee, C.S.; Tsai, W.Y.; Santella, R.M. p53 Mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 1997, 57, 3471-3477.
50. Henson, J.D.; Neumann, A.A.; Yeager, T.R.; Reddel, R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 2002, 21, 598-610.
51. Ohki, S.; Onda, M.; Fukushima, T.; Takita, K.; Suzuki, S.; Hoshino, M.; Tsuchiya, A.; Abe, R.; Takenoshita, S. Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene. Int. J. Mol. Med. 2003, 11, 485-490.
52. Farazi, P.A.; Glickman, J.; Horner, J.; DePinho, R.A. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. Cancer Res. 2006, 66, 4766-4773.
53. Bechter, O.E.; Eisterer, W.; Dlaska, M.; Kuhr, T.; Thaler, J. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp. Hematol. 2002, 30, 26-33.
54. Garcia-Cao, M.; O'Sullivan, R.; Peters, A.H.; Jenuwein, T.; Blasco, M.A. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 2004, 36, 94-99.
55. Gonzalo, S.; Jaco, I.; Fraga, M.F.; Chen, T.; Li, E.; Esteller, M.; Blasco, M.A. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat.Cell Biol. 2006, 8, 416-424.